Upgrade to SI Premium - Free Trial

BeOne Medicines (ONC)

279.93 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/21/26)

Latest Headlines

Form 4 BeOne Medicines Ltd. For: Jun 01 Filed by: Yi Qingqing June 3, 2026 4:10 PM - SEC Filing BeOne Medicines (ONC) Reiterated at Market Outperform by Citizens June 3, 2026 4:41 AM - StreetInsider BeOne Medicines (ONC) PT Raised to $436 at RBC Capital June 2, 2026 7:16 AM - StreetInsider BeOne Medicines Highlights Accelerating Solid Tumor Pipeline with New Data at ASCO 2026 June 1, 2026 6:00 AM - BizWire BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 2026 May 29, 2026 6:00 AM - BizWire JPMorgan says large-cap biotech is back as profits and pipelines fuel upside May 28, 2026 4:07 PM - StreetInsider Form 4 BeOne Medicines Ltd. For: May 22 Filed by: Riva Alessandro May 27, 2026 5:29 PM - SEC Filing Form 4 BeOne Medicines Ltd. For: May 22 Filed by: Dugan Margaret May 27, 2026 5:27 PM - SEC Filing Form 4 BeOne Medicines Ltd. For: May 22 Filed by: Sanders Corazon (Corsee) D. May 27, 2026 5:26 PM - SEC Filing BeOne Medicines reports positive phase 3 cancer trial results May 27, 2026 5:00 PM - StreetInsider BeOne Medicines Announces Phase 3 HERIZON-GEA Data Published in NEJM and Presented at ASCO 2026 May 27, 2026 5:00 PM - BizWire Form 4 BeOne Medicines Ltd. For: May 22 Filed by: 667, L.P. May 27, 2026 4:54 PM - SEC Filing BeOne Medicines to Present at the Goldman Sachs 47th Annual Global Healthcare Conference May 26, 2026 6:01 AM - BizWire BeOne Medicines Sets the Pace in Oncology at ASCO and EHA 2026 with 60+ Abstracts May 21, 2026 6:00 AM - BizWire JPMorgan sees biotech sector at inflection point, resumes coverage on 14 Firms May 20, 2026 3:10 PM - StreetInsider BeOne Medicines Launches One Save Changes Everything, a Global Cancer Care Awareness Campaign with Soccer Legend Tim Howard May 20, 2026 6:00 AM - BizWire JPMorgan Reinstates BeOne Medicines (ONC) at Overweight May 20, 2026 4:30 AM - StreetInsider Form 3/A BeOne Medicines Ltd. For: Sep 27 Filed by: Sharp Shalini May 15, 2026 4:43 PM - SEC Filing Form 4 BeOne Medicines Ltd. For: May 13 Filed by: Lee Chan Henry May 15, 2026 4:42 PM - SEC Filing BeOne Medicines wins FDA approval for mantle cell lymphoma drug May 13, 2026 1:28 PM - StreetInsider BeOne Medicines’ BEQALZI™ (sonrotoclax) Approved by U.S. FDA as First and Only BCL2 Inhibitor for R/R Mantle Cell Lymphoma May 13, 2026 1:27 PM - BizWire BeOne Medicines (ONC) PT Raised to $395 at Morgan Stanley May 7, 2026 9:00 AM - StreetInsider BeOne Medicines (ONC) PT Raised to $425 at RBC Capital May 7, 2026 8:22 AM - StreetInsider BeOne Medicines (ONC) PT Raised to $453 at Citi May 7, 2026 7:37 AM - StreetInsider BeOne Medicines (ONC) PT Raised to $413 at Truist Securities May 7, 2026 7:11 AM - StreetInsider BeOne Medicines (ONC) PT Raised to $420 at Guggenheim May 7, 2026 6:39 AM - StreetInsider BeOne Medicines (ONC) PT Raised to $409 at Barclays May 7, 2026 4:00 AM - StreetInsider BeOne Medicines Announces First Quarter 2026 Financial Results and Business Updates May 6, 2026 6:00 AM - BizWire FDA grants priority review to BeOne's cancer drug combination April 29, 2026 6:00 AM - StreetInsider U.S. FDA Grants Priority Review to BeOne Medicines’ TEVIMBRA in First-Line HER2+ GEA April 29, 2026 6:00 AM - BizWire BeOne Medicines to Announce First Quarter 2026 Financial Results on May 6 April 22, 2026 6:01 AM - BizWire BeOne Medicines (ONC) Reiterated at Market Outperform by Citizens After PRMT5i Presentation April 20, 2026 5:35 AM - StreetInsider Form 4 BeOne Medicines Ltd. For: Apr 08 Filed by: Lee Chan Henry April 10, 2026 5:40 PM - SEC Filing BeOne Medicines (ONC) PT Lowered to $411 at Truist Securities April 8, 2026 6:06 AM - StreetInsider BeOne Medicines (ONC) PT Lowered to $423 at RBC Capital April 7, 2026 9:05 AM - StreetInsider Wolfe Research Starts BeOne Medicines (ONC) at Outperform March 26, 2026 4:11 PM - StreetInsider Jefferies says these are the best SMID-cap biotech stocks to buy March 22, 2026 10:00 AM - StreetInsider Jefferies Downgrades BeOne Medicines (ONC) to Hold March 16, 2026 12:56 AM - StreetInsider Form 4 BeOne Medicines Ltd. For: Mar 11 Filed by: Lee Chan Henry March 13, 2026 5:26 PM - SEC Filing Form 4 BeOne Medicines Ltd. For: Mar 06 Filed by: OYLER JOHN March 10, 2026 8:14 PM - SEC Filing Form 4 BeOne Medicines Ltd. For: Mar 06 Filed by: Lee Chan Henry March 10, 2026 8:14 PM - SEC Filing Form 4 BeOne Medicines Ltd. For: Mar 06 Filed by: Wang Lai March 10, 2026 8:13 PM - SEC Filing Form 4 BeOne Medicines Ltd. For: Mar 06 Filed by: Wu Xiaobin March 10, 2026 8:12 PM - SEC Filing Form 4 BeOne Medicines Ltd. For: Mar 06 Filed by: Rosenberg Aaron March 10, 2026 8:12 PM - SEC Filing Full Article List